Related Experiment Video
Updated: Aug 9, 2026
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Neuroprotective agents in schizophrenia and affective disorders
Michael Krebs1, Karolina Leopold, Axel Hinzpeter
1Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Campus Charité Mitte, Schumannstr. 20/21, D-10117 Berlin, Germany. Michael.Krebs@charite.de
Expert Opinion on Pharmacotherapy
|April 26, 2006
Summary
Neuroprotective agents show promise for treating psychiatric disorders like schizophrenia and affective disorders by targeting neurodegeneration. Current research explores various add-on therapies to enhance treatment efficacy.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Neurodegenerative mechanisms are increasingly implicated in the pathophysiology of schizophrenia and affective disorders.
- While not established for all psychiatric conditions, neuroprotection shows potential beyond dementia.
- Existing psychiatric medications like antipsychotics, mood stabilizers, and antidepressants exhibit in vitro and in vivo neuroprotective effects.
Purpose of the Study:
- To review current neuroprotective treatment options for psychiatric disorders.
- To focus on the application of neuroprotective agents in schizophrenia and affective disorders.
- To highlight emerging add-on therapies being evaluated for these conditions.
Main Methods:
- Review of current literature on neuroprotective agents in psychiatric disorders.
- Analysis of data from brain imaging studies and clinical trials.
- Examination of in vitro and in vivo evidence for neuroprotective effects of existing medications.
Main Results:
- Second-generation antipsychotics, mood stabilizers, and antidepressants demonstrate neuroprotective properties.
- Several agents (modafinil, erythropoietin, glycine, D-serine, memantine, celecoxib) are under investigation as add-on therapies.
- Neuroprotective strategies are being actively explored for schizophrenia and related disorders.
Conclusions:
- Neuroprotective agents represent a potential therapeutic avenue for schizophrenia and affective disorders.
- Further research and clinical evaluation are warranted for these emerging treatments.
- Targeting neurodegeneration may offer novel approaches to managing complex psychiatric conditions.
Related Concept Videos
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:21Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...